Marbles Health

Marbles Health operates at the intersection of medical devices, mental health treatment and digital therapeutics, with a focus on neuromodulation rather than software-only care. Its primary differentiation is the integration of stimulation, EEG feedback and cognitive-emotional training in a portable headband designed for supervised use at home or in clinics. Compared with single-function stimulation devices, ease is positioned as a multimodal system with clinician-guided treatment plans and built-in session safety checks. Compared with purely virtual mental-health platforms, it incorporates a regulated physical device and physiological monitoring. CDSCO approval, reported use by more than 100 Indian clinicians and more than 25,000 delivered sessions provide concrete indicators of market activity.

Marbles Health appears to have progressed from its 2020 founding into product deployment in India, with ease serving as the main commercial and clinical platform. The most significant inflection point is the combination of CDSCO approval and reported adoption by more than 100 neurologists, psychiatrists and neuropsychiatry clinicians. More than 25,000 delivered sessions suggest usage beyond an early prototype, while the inclusion of home and in-clinic workflows indicates an effort to expand access without removing clinical oversight. The product’s integrated EEG monitoring, tDCS and Cognitive Emotional Training approach also broadens the potential treatment model beyond standalone stimulation. Growth cannot be quantified financially: no funding rounds, valuation, revenue figures or investor information are publicly available in the current profile. Employee information places the company in the 11-to-50 employee range, but there is no time series showing hiring acceleration. The trajectory therefore shows product and clinical-use progression, but limited evidence for capital-backed scaling or international commercialization.